• pharma
  • pharmapharma

YOU MIGHT BE INTERESTED IN

  1. Global Clinical Trial Business Report & Analysis 2008-2018

    Global Clinical Trial Business Report & Analysis 2008-2018

    The global clinical trials business is worth an estimated $50bn in 2008, with a growth of rate of 10%. The market will show considerable growth in the future, as this visiongain report, Global Clinical Trial Business 2008-2018, explains in detail. In recent years, the nature of clinical trials has changed considerably.

    ...more details
  2. World Generics Market, 2008-2013

    World Generics Market, 2008-2013

    The generics market remains a major growth area in the global healthcare market. That growth has been partly driven by cost-containment in several national healthcare sectors, with governments seeking to promote the use of generic products over higher-priced originator products. The global generic pharmaceuticals market was worth over $100bn in 2007, with market growth noticeably higher that that of the overall pharmaceutical market.

    ...more details
  3. Contract Pharma 2008-2023

    Contract Pharma 2008-2023

    The revenue for world contract manufacturing business in 2007 was approximately $30bn, with a growth rate of 6% from 2006. The technical expertise and cost savings offered by contract manufacturing organisations (CMOs) make them increasingly essential to you and your organisation.

    ...more details

CONFERENCE PRODUCTS

rss_Pharma.jpg
3rd Annual Clinical Trials Conference 2009

3rd Annual Clinical Trials Conference 2009

Improving clinical trials efficacy while ensuring regulatory compliance

29th - 30th June 2009, BSG Conference Centre, London, UK

Conference only

£1299

Promotional Literature Distribution

Distribution of your company’s promotional literature to all conference attendees

£999